With over twenty years of experience delivering results for venture capital-backed SaaS companies, Richard Resnick leads Cureatr as Chief Executive Officer. Before joining Cureatr, Richard was the CEO of GQ Life Sciences, a SaaS enterprise in the life sciences backed by Milestone Venture Partners, Cross Atlantic Partners, Mosaix Ventures, and SGAM, which he led to a successful acquisition by Aptean in 2016. As a respected industry thought leader, Richard speaks publicly on trends in technology and healthcare including his TED Talk, “Welcome to the genomic revolution.” Resnick holds an M.B.A. from the MIT Sloan School of Management, an M.S. in Computer Science from Worcester Polytechnic Institute, and a B.S in Computer Science from the University of Massachusetts at Amherst.
Cureatr is a comprehensive medication management (CMM) solutions company dedicated to repairing the United States’ $528 Billion, 275,000 deaths a year suboptimal medication management problem. We provide real-time, universal access to accurate medication data for over 265 Million patient and high-quality interventions by board certified telepharmacists. We have the expertise, resources, and technology to help you get the meds right and keep your patients out of the hospital.